Literature DB >> 17886264

Alpha-1-antitrypsin mutant Z protein content in individual hepatocytes correlates with cell death in a mouse model.

Douglas Lindblad1, Keith Blomenkamp, Jeffrey Teckman.   

Abstract

UNLABELLED: Alpha-1-antitrypsin (a1AT) deficiency is caused by homozygosity for the a1AT mutant Z gene and occurs in 1 in 2000 births. The Z mutation confers an abnormal conformation on the protein, resulting in an accumulation within the endoplasmic reticulum of hepatocytes rather than appropriate secretion. The accumulation of the mutant protein is strikingly heterogeneous within the liver. Homozygous ZZ children and adults have an increased risk of chronic liver disease, which is thought to result from this variable intracellular accumulation of the a1AT mutant Z protein. Previous reports have suggested that autophagy, mitochondrial injury, apoptosis, and other pathways may be involved in the mechanism of hepatocyte injury, although the interplay of these mechanisms in vivo is unclear. In this study, we examine a well-characterized in vivo model of a1AT mutant Z liver injury, the PiZ mouse, to better understand the pathways involved in this disease. The results show an increase in the stimulation of the apoptotic cascade in hepatocytes, the magnitude of which strongly correlates to the absolute amount of the a1AT mutant Z protein accumulated within the individual cell. Increases in apoptotic regulatory proteins are also detected.
CONCLUSION: These data, combined with previous work, permit for the first time the construction of a hypothetical hepatocellular injury cascade for this disease involving mitochondrial injury, caspase activation, and apoptosis, which takes into account the heterogeneous nature of the mutant Z protein accumulation within the liver. Further development of this hypothetical cascade will focus future research on this and other metabolic liver diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17886264     DOI: 10.1002/hep.21822

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  28 in total

Review 1.  Novel treatment strategies for liver disease due to α1-antitrypsin deficiency.

Authors:  Nicholas Maurice; David H Perlmutter
Journal:  Clin Transl Sci       Date:  2012-01-10       Impact factor: 4.689

2.  Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.

Authors:  Elizabeth M Brunt; Keith Blomenkamp; Muneeb Ahmed; Faiza Ali; Nancy Marcus; Jeffrey Teckman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-11       Impact factor: 2.839

3.  Don't Miss the BoAAT: Correctly Diagnosing Acute-on-Chronic Liver Disease.

Authors:  Zain A Sobani; Graziella R Paniz; Morgan Wong; Denis M McCarthy
Journal:  Dig Dis Sci       Date:  2019-10       Impact factor: 3.199

4.  Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice.

Authors:  Shuling Guo; Sheri L Booten; Mariam Aghajan; Gene Hung; Chenguang Zhao; Keith Blomenkamp; Danielle Gattis; Andrew Watt; Susan M Freier; Jeffery H Teckman; Michael L McCaleb; Brett P Monia
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

Review 5.  Advances in alpha-1-antitrypsin deficiency liver disease.

Authors:  Jeffrey H Teckman; Ajay Jain
Journal:  Curr Gastroenterol Rep       Date:  2014-01

6.  CHOP and c-JUN up-regulate the mutant Z α1-antitrypsin, exacerbating its aggregation and liver proteotoxicity.

Authors:  Sergio Attanasio; Rosa Ferriero; Gwladys Gernoux; Rossella De Cegli; Annamaria Carissimo; Edoardo Nusco; Severo Campione; Jeffrey Teckman; Christian Mueller; Pasquale Piccolo; Nicola Brunetti-Pierri
Journal:  J Biol Chem       Date:  2020-07-28       Impact factor: 5.157

7.  Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency.

Authors:  Nancy Y Marcus; Elizabeth M Brunt; Keith Blomenkamp; Faiza Ali; David A Rudnick; Muneeb Ahmad; Jeffrey H Teckman
Journal:  Hepatol Res       Date:  2010-06       Impact factor: 4.288

8.  The ubiquitin ligase Hrd1 promotes degradation of the Z variant alpha 1-antitrypsin and increases its solubility.

Authors:  Haiping Wang; Qi Li; Yujun Shen; Aimin Sun; Xiaoguang Zhu; Shengyun Fang; Yuxian Shen
Journal:  Mol Cell Biochem       Date:  2010-10-01       Impact factor: 3.396

9.  Bile Duct Ligation Induces ATZ Globule Clearance in a Mouse Model of α-1 Antitrypsin Deficiency.

Authors:  Zahida Khan; Shinichiro Yokota; Yoshihiro Ono; Aaron W Bell; Michael Oertel; Donna B Stolz; George K Michalopoulos
Journal:  Gene Expr       Date:  2016-08-18

10.  Spontaneous hepatic repopulation in transgenic mice expressing mutant human α1-antitrypsin by wild-type donor hepatocytes.

Authors:  Jianqiang Ding; Govardhana R Yannam; Namita Roy-Chowdhury; Tunda Hidvegi; Hesham Basma; Stephen I Rennard; Ronald J Wong; Yesim Avsar; Chandan Guha; David H Perlmutter; Ira J Fox; Jayanta Roy-Chowdhury
Journal:  J Clin Invest       Date:  2011-04-18       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.